Opioid cessation products under attack by FTC & FDA

Together with the FDA, the FTC issued joint warning letters to 11 marketers and producers of allegedly unapproved opioid cessation products.  The letters allege that the companies used online platforms to make unsubstantiated claims about their products’ ability to treat opioid addiction and withdrawal.  Letters were sent to: Opiate Freedom Center (Opiate Freedom 5-Pack) U4Life, […]

Homeopathic drugs held to same standards by the FTC

In late September 2015, the FTC hosted a one-day public workshop, titled “Homeopathic Medicine & Advertising.”  The workshop explored advertising for over-the-counter (“OTC”) homeopathic drugs.  The workshop included several panel discussions.  The topics explored by the panel discussions touched on issues such as the current state of the homeopathic market, advertising for homeopathic products, consumer […]

POM Wonderful appeal denied by Supreme Court

The U.S. Supreme Court has declined to hear POM Wonderful LLC’s petition for writ of certiorari regarding a 2013 FTC decision that found some of POM Wonderful’s health related claims to be misleading.  As a result, the FTC ‘s January 2013 order against POM Wonderful will stand. FTC’s REsponse to Supreme Court’s Denial of Appeal […]